Tom Wagler

Mersana Therapeutics is a clinical-stage biopharmaceutical company with an innovative and differentiated antibody drug conjugates (ADCs) pipeline that is built upon novel linker platforms such as Dolaflexin® and Dolasynthen that deliver proprietary auristatin-based payloads via the state-of-the-art…